共 349 条
[1]
Endo J(2016)Cardioprotective mechanism of omega-3 polyunsaturated fatty acids J Cardiol 67 22-27
[2]
Arita M(2016)Eicosapentaenoic acid reduces membrane fluidity, inhibits cholesterol domain formation, and normalizes bilayer width in atherosclerotic-like model membranes Biochim Biophys Acta 1858 3131-3140
[3]
Mason RP(2005)Omega-3 fatty acids and the regulation of expression of endothelial pro-atherogenic and pro-inflammatory genes J Membr Biol 206 103-116
[4]
Jacob RF(2016)Targeting inflammation in metabolic syndrome Transl Res 167 257-280
[5]
Shrivastava S(2014)Inflammation and its resolution as determinants of acute coronary syndromes Circ Res 114 1867-1879
[6]
Sherratt SCR(2021)Regression of human coronary artery plaque is associated with a high ratio of (18-hydroxy-eicosapentaenoic acid + resolvin E1) to leukotriene B4 FASEB J 35 98-1895
[7]
Chattopadhyay A(2015)Effects of omega-3 carboxylic acids on lipoprotein particles and other cardiovascular risk markers in high-risk statin-treated patients with residual hypertriglyceridemia: a randomized, controlled, double-blind trial Lipids Health Dis 14 1885-338
[8]
De Caterina R(2013)Efficacy and safety of ezetimibe added to atorvastatin versus atorvastatin uptitration or switching to rosuvastatin in patients with primary hypercholesterolemia Am J Cardiol 112 335-509
[9]
Massaro M(2020)Eicosapentaenoic acid (EPA) has optimal chain length and degree of unsaturation to inhibit oxidation of small dense LDL and membrane cholesterol domains as compared to related fatty acids in vitro Biochim Biophys Acta Biomembr 1862 502-1237
[10]
Welty FK(2018)Eicosapentaenoic acid inhibits oxidation of high density lipoprotein particles in a manner distinct from docosahexaenoic acid Biochem Biophys Res Commun 496 1231-162